ID   RPMI-7932 VBL-4
AC   CVCL_RW17
SY   VBL-4; VBL 4
DR   Wikidata; Q54951233
RX   PubMed=3180053;
RX   PubMed=7954423;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2713 ! RPMI-7932
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 4
//
RX   PubMed=3180053;
RA   Lemontt J.F., Azzaria M., Gros P.;
RT   "Increased mdr gene expression and decreased drug accumulation in
RT   multidrug-resistant human melanoma cells.";
RL   Cancer Res. 48:6348-6353(1988).
//
RX   PubMed=7954423;
RA   Porter C.W., Ganis B., Rustum Y.M., Wrzosek C., Kramer D.L.,
RA   Bergeron R.J.;
RT   "Collateral sensitivity of human melanoma multidrug-resistant variants
RT   to the polyamine analogue, N1,N11-diethylnorspermine.";
RL   Cancer Res. 54:5917-5924(1994).
//